NRC Health Net Income (Loss) Available to Common Stockholders, Diluted
NRC Health (NRC) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$3.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-04
- NRC Health net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$3.30M.
- NRC Health net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $3.09M, a 46.62% decline year-over-year.
- NRC Health net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $3.99M, a 29.78% decline year-over-year.
- NRC Health net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$190.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-06-30 | -$3.30M 10-Q · filed 2026-08-04 | -$214.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $3.09M 10-Q · filed 2026-05-06 | ||
| 2025-09-30 | $3.99M 10-Q · filed 2025-11-07 | $3.80M derived: sum of 2 quarters · filed 2026-08-04 | $9.63M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$190.00K 10-Q · filed 2026-08-04 | $5.59M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $5.79M 10-Q · filed 2026-05-06 | ||
| 2024-09-30 | $5.69M 10-Q · filed 2025-11-07 | $18.22M 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |